002872.SZ
Tiansheng Pharmaceutical Group Co. Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.52
−0.72%Year over year
Reported trailing growth
- Revenue
- -1.3%
- EBITDA
- —
- EBIT
- +30.4%
- EPS
- +33.5%
- Free cash flow
- —
- Operating cash flow
- -84.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.4%
- EBITDA
- +38.4%
- EBIT
- +32.9%
- Net income
- +36.6%
- EPS
- +36.6%
- Free cash flow
- +0.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026